投资者关系
Information disclosure Stock Information Presentation Materials and Newsletter Corporate Governance Investor Calendar Investor Enquiries
Bimonthly Newsletter Vol.2 2022
2022-04-30 16:11:24
上一篇：Peijia Medical’s SyphonetⓇ Stent Retriever Receives NMPA Approval for Commercialization
下一篇：Peijia Medical Announced 2021 Annual Results Dual Engines in the Fast Lane of Commercialization, Tot
Top